The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.
Recruiting
N/A
Interventional Study
Heart Failure
Heart Failure With Reduced Ejection Fraction
Obesity
Overweight
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 110 (estimated)
- Sponsor
- University of Oxford · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study looks at the effects of weight loss in people who have heart failure with reduced ejection fraction (HFpEF) and are overweight or obese.
The main questions it aims to answer are whether weight loss in this group of people improves:
* The heart's shape and how well it pumps blood
* The person's quality of life and how much they can exercise
Participants will attend 2 study visits, sep…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Heart failure determined by left ventricular ejection fraction 20-45%
* Body mass index \> 27.5kg/m\^2
Exclusion Criteria:
* Contraindications to magnetic resonance imaging
* NYHA class IV
* Pregnancy, planned pregnancy or lactating
* Significant valvular, ischemic, infiltra…
Contacts